Characteristics of Patients With Nonalcoholic Steatohepatitis Who Develop Hepatocellular Carcinoma

Clinical Gastroenterology and Hepatology

Volumn 9, Issue 5, 2011, Pages 428-433

  Yasui, Kohichiroh ^a   Hashimoto, Etsuko ^b   Komorizono, Yasuji ^c   Koike, Kazuhiko ^d   Arii, Shigeki ^e   Imai, Yasuharu ^f   Shima, Toshihide ^g   Kanbara, Yoshihiro ^g   Saibara, Toshiji ^h   Mori, Takahiro ⁱ   Kawata, Sumio ^j   Uto, Hirofumi ^k   Takami, Shiro ^l   Sumida, Yoshio ^m   Takamura, Toshinari ⁿ   Kawanaka, Miwa ^o   Okanoue, Takeshi ^a,g  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c Nanpuh Hospital   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^f Ikeda Municipal Hospital   (Japan)

^g Saiseikai Imperial Gift Foundation Inc Saiseikai Suita Hospital   (Japan)

^h KOCHI MEDICAL SCHOOL   (Japan)

ⁱ Osaka Railway Hospital   (Japan)

^j YAMAGATA UNIVERSITY   (Japan)

^k KAGOSHIMA UNIVERSITY   (Japan)

^l OTSU MUNICIPAL HOSPITAL   (Japan)

^m Nara City Hospital   (Japan)

ⁿ KANAZAWA UNIVERSITY   (Japan)

^o KAWASAKI MEDICAL SCHOOL   (Japan)

more..

Author keywords

Incidence; Liver Cancer; Retrospective Study; Sex

Indexed keywords

AGED; ARTICLE; BODY MASS; CANCER GROWTH; CLINICAL FEATURE; DYSLIPIDEMIA; FEMALE; HUMAN; HUMAN TISSUE; HYPERTENSION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; SEX DIFFERENCE;

AGED; CARCINOMA, HEPATOCELLULAR; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; FATTY LIVER; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; HYPERTENSION; JAPAN; LIVER; LIVER NEOPLASMS; MALE; OBESITY; RISK FACTORS; SEX DISTRIBUTION;

EID: 79955033727     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2011.01.023     Document Type: Article

References (39)

1. Parkin D.M. Global cancer statistics in the year 2000. Lancet Oncol 2001, 2:533-543.
2. El-Serag H.B., Rudolph K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132:2557-2576.
3. Farrell G.C., Larter C.Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006, 43:S99-S112.
4. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002, 346:1221-1231.
5. Powell E.E., Cooksley W.G., Hanson R., et al. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990, 11:74-80.
6. Cotrim H.P., Paraná R., Braga E., et al. Nonalcoholic steatohepatitis and hepatocellular carcinoma: natural history?. Am J Gastroenterol 2000, 95:3018-3019.
7. Zen Y., Katayanagi K., Tsuneyama K., et al. Hepatocellular carcinoma arising in non-alcoholic steatohepatitis. Pathol Int 2001, 51:127-131.
8. Shimada M., Hashimoto E., Taniai M., et al. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol 2002, 37:154-160.
9. Marrero J.A., Fontana R.J., Su G.L., et al. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 2002, 36:1349-1354.
10. Bugianesi E., Leone N., Vanni E., et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002, 123:134-140.
11. Ratziu V., Bonyhay L., Di Martino V., et al. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology 2002, 35:1485-1493.
12. Regimbeau J.M., Colombat M., Mognol P., et al. Obesity and diabetes as a risk factor for hepatocellular carcinoma. Liver Transpl 2004, 10:S69-S73.
13. Adams L.A., Lymp J.F., St Sauver J., et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005, 129:113-121.
14. Sanyal A.J., Banas C., Sargeant C., et al. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C. Hepatology 2006, 43:682-689.
15. Hashimoto E., Yatsuji S., Tobari M., et al. Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. J Gastroenterol 2009, 44:89-95.
16. Yatsuji S., Hashimoto E., Tobari M., et al. Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C. J Gastroenterol Hepatol 2009, 24:248-254.
17. Ascha M.S., Hanouneh I.A., Lopez R., et al. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 2010, 51:1972-1978.
18. Okanoue T., Umemura A., Yasui K., et al. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan. J Gastroenterol Hepatol 2011, 26(Suppl 1):153-162.
19. Bruix J., Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236. Practice Guidelines Committee, American Association for the Study of Liver Diseases.
20. New criteria of obesity (in Japanese). J Jpn Soc Study Obes 2000, 6:18-28. Japan Society for the Study of Obesity.
21. Kuzuya T., Nakagawa S., Satoh J., et al. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract 2002, 55:65-85.
22. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults.
23. Matteoni C.A., Younossi Z.M., Gramlich T., et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999, 116:1413-1419.
24. Kleiner D.E., Brunt E.M., Van Natta M., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41:1313-1321.
25. Brunt E.M. Non-alcoholic fatty liver disease. MacSween's pathology of the liver 2006, 367-397. Churchill Livingstone, London. 5th ed. A.D. Burt, B.C. Portmann, L.D. Ferrell (Eds.).
26. Brunt E.M., Janney C.G., Di Bisceglie A.M., et al. Non-alcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999, 94:2467-2474.
27. Ikai I., Arii S., Okazaki M., et al. Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan. Hepatol Res 2007, 37:676-691.
28. Bugianesi E. Non-alcoholic steatohepatitis and cancer. Clin Liver Dis 2007, 11:191-207.
29. Neuschwander-Tetri B.A., Caldwell S.H. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 2003, 37:1202-1219.
30. Sumida Y., Yoneda M., Hyogo H., et al. A simple clinical scoring system using ferritin, fasting insulin and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease. J Gastroenterol 2011, 46:257-268.
31. Calle E.E., Rodriguez C., Walker-Thurmond K., et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003, 348:1625-1638.
32. Caldwell S., Park S.H. The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology. J Gastroenterol 2009, 44:96-101.
33. Bullock R.E., Zaitoun A.M., Aithal G.P., et al. Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma. J Hepatol 2004, 41:685-686.
34. Ichikawa T., Yanagi K., Motoyoshi Y., et al. Two cases of non-alcoholic steatohepatitis with development of hepatocellular carcinoma without cirrhosis. J Gastroenterol Hepatol 2006, 21:1865-1866.
35. Guzman G., Brunt E.M., Petrovic L.M., et al. Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis?. Arch Pathol Lab Med 2008, 132:1761-1766.
36. Kawada N., Imanaka K., Kawaguchi T., et al. Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis. J Gastroenterol 2009, 44:1190-1194.
37. Paradis V., Zalinski S., Chelbi E., et al. Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis. Hepatology 2009, 49:851-859.
38. Adamson J.W. Hematopoietic disorders. Harrison's principles of internal medicine 2008, 628-634. McGraw-Hill Companies, New York. 17th ed. A.S. Fauci, E. Braunwald, D.L. Kasper (Eds.).
39. Bonkovsky H.L., Jawaid Q., Tortorelli K., et al. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis. J Hepatol 1999, 31:421-429.